PharmaBiome
PrivateLast Round
Seed
Jul 8, 2020
Total Funding Raised
$2.45M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
PharmaBiome is a biotechnology company that develops a drug development platform for targeted microbiome therapeutics to treat diseases caused by functional deficiencies in the microbiome.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PharmaBiome Comparables
Compare PharmaBiome with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MarvelBiome Inc. | 87% | |
| ImmunoBiome Inc. | 84% | |
| mbiomics GmbH | 81% | |
PharmaBiome Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 8, 2020 | ||||
| Grant | Apr 23, 2020 | ||||
| Accelerator | Jan 16, 2020 | ||||
| Grant | May 22, 2019 | ||||
| Grant | Dec 1, 2017 | ||||
Grant | Jun 14, 2016 |
PharmaBiome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| W.A. de Vigier Foundation | Grant |
| BaseLaunch | Accelerator |
| Venture Kick | Grant |
| Zurcher Kantonalbank | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors increased 1915% MoM, from 46 to 927.
- May 3, 2025
Monthly visitors grew 31% MoM, reaching 1K.
PharmaBiome Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PharmaBiome's valuation, stock price, and market status.